Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Professional Case Management|February 6, 2018
Decision-Making Data: Expectations for Reproducibility of Lifting on Separate DaysMarcie C Swift, Robert Townsend, Douglas W Edwards, et al.Work (Reading, Mass.)|December 2, 2011
Accuracy of visual estimation in classifying effort during a lifting taskDarrell W Schapmire, James D St James, Robert Townsend, et al.American Economic Journal. Applied Economics|April 26, 2014
Barriers to Household Risk Management: Evidence from IndiaShawn Cole, Xavier Giné, Jeremy Tobacman, et al.Journal of Shoulder and Elbow Surgery|April 1, 2017
Low-grade infections in nonarthroplasty shoulder surgeryUmair Khan, Emma Torrance, Robert Townsend, et al.International Journal of Occupational Safety and Ergonomics : JOSE|January 5, 2022
Tactical vests worn by law enforcement: is this improving stability for optimal job performance?Andrew Shim, David Shannon, Mike Waller, et al.International Journal of Clinical Pharmacology and Therapeutics|June 28, 2016
Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pHAnne Schmitt-Hoffmann, Amit Desai, Donna Kowalski, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 27, 2015
Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled studyRobert Townsend, Amit Desai, Diane Rammelsberg, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohortsMatthew J Everly, Mustimbo Roberts, Robert Townsend, et al.Antimicrobial Agents and Chemotherapy|July 7, 2016
Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous FungiAmit Desai, Laura Kovanda, Donna Kowalski, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 22, 2006
Surviving sepsis campaign: a project to change sepsis trajectoryEliezer Silva, Nelson Akamine, Reinaldo Salomao, et al.Pageof 6